Press Resources

Xstrahl is a medical technology company that designs clinical and research systems to help eradicate cancer. For more than 30 years, Xstrahl has been shaping the development of superficial and orthovoltage therapies for cancer treatment and advancing pre-clinical research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.

Xstrahl superficial and orthovoltage systems deliver superior low-energy radiation treatment for skin cancer, providing maximum comfort to the patient without surgical risks. For skin cancer, low-energy treatments provide better clinical results for patients than conventional radiation therapy using a linear accelerators. Xstrahl low-energy radiation therapy systems are available in mobile and wall-mounted configurations and many different treatment energies (100 kV, 150kV, 200kV, 300kV) depending on the clinician’s needs and patient mix. Xstrahl cancer therapy systems are currently used at leading cancer therapy institutions worldwide.

Xstrahl offers both 3D X-ray irradiators and free standing systems to drive clinically relevant research forward with functionality and reproducibility. Xstrahl’s SARRP system is the first choice of radiation biology researchers worldwide due to its ability to mimic clinical radiation therapy using combination of high resolution CT imaging, dynamic couch and gantry movements, and intuitive treatment planning software. Xstrahl’s research cabinets are highly versatile, providing various depths and configurations with backing of an expert customer support team.

Press information contact: Adrian Treverton, CEO

Adrian Treverton

Chief Executive Officer

Adrian had more than 10 years of industry leadership experience before coming to Xstrahl, as an International sales manager in 2006. As Sales Director, he took the lead on building up Xstrahl’s distributor network and growing the US subsidiary, ultimately moving to the USA in 2011 to continue his work with the Life Science brand. In 2013 Adrian was appointed Chief Operations Officer and continued to build a strong team around him. In 2017 after a management buy out Adrian was promoted to Group CEO.

 

adrian

System Logos

Click below to download our corporate brochure.

User Spotlights

Xstrahl Medical

The Xstrahl 150 is perfectly suited to treating a range of superficial and benign conditions thanks to its versatile design offering both orthovoltage and superficial treatment techniques in one system. Dr John Glees takes advantage of the system’s adaptability to treat a range of non-melanoma skin cancers and dermatological conditions such as Dupuytren’s and Ledderhose.

 

The Xstrahl 100 is perfectly suited for the treatment of superficial skin cancers, and with Australia recording skin cancer rates of 2 in 3 people, the need for an effective and versatile treatment method is needed. With a rise in cosmetically focused patients, Just Skin Treatment Clinic have partnered with the Xstrahl 100 to deliver highly beneficial results.

 

With skin cancer being the most common type of cancer in the USA the need for an effective and versatile treatment method is a necessity for many skin cancer centers. The Xstrahl 100 is perfectly suited for the treatment of superficial skin cancers, as used by the SCARS center in California.

 

Non-melanoma skin cancers (NMSC) are the most commonly diagnosed cancers in the world. Despite their relatively low malignant potential and mortality rate, NMSC are associated with a high morbidity and substantial treatment cost, and they significantly affect patient quality of life.

 

Xstrahl Life Science

The Radiobiology Research Group from the Centre for Cancer Research and Cell Biology at Queen’s University Belfast published a series of articles using SARRP to explore different translationally focused experimental approaches.

 

Immunotherapy has become the most promising advancement in cancer treatment. One of the institutions leading the advancement of this type of research is the Earle A. Chiles Research Institute at Providence Cancer Center.
Please fill out your details below to download our brochures. Your only need to do once to unlock access.
Send